State Street’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

State Street’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.42K	Hold	315	–	–	﹤0.01%	4253
2025 Q4	$9.14K	Hold	315	–	–	﹤0.01%	4271
2025 Q3	$5.28K	Hold	315	–	–	﹤0.01%	4276
2025 Q2	$26K	Hold	315	–	–	﹤0.01%	4179
2025 Q1	$24.9K	Hold	315	–	–	﹤0.01%	4181
2024 Q4	$52.8K	Hold	315	–	–	﹤0.01%	4102
2024 Q3	$29.6K	Hold	315	–	–	﹤0.01%	4177
2024 Q2	$31.1K	Buy	315 +82	+35%	+$10.2K	﹤0.01%	4223
2024 Q1	$35.8K	Hold	233	–	–	﹤0.01%	4210
2023 Q4	$27.2K	Hold	233	–	–	﹤0.01%	4302
2023 Q3	$46.7K	Hold	233	–	–	﹤0.01%	4302
2023 Q2	$47.4K	Hold	233	–	–	﹤0.01%	4431
2023 Q1	$35.9K	Hold	233	–	–	﹤0.01%	4583
2022 Q4	$31.5K	Hold	233	–	–	﹤0.01%	4659
2022 Q3	$47K	Hold	233	–	–	﹤0.01%	4670
2022 Q2	$82K	Buy	233 +7	+3%	+$2.94K	﹤0.01%	4598
2022 Q1	$133K	Sell	226 -378	-63%	-$225K	﹤0.01%	4537
2021 Q4	$555K	Hold	604	–	–	﹤0.01%	3980
2021 Q3	$756K	Buy	604 +10	+2%	+$19.4K	﹤0.01%	3850
2021 Q2	$1.88M	Sell	594 -472	-44%	-$1.87M	﹤0.01%	3560
2021 Q1	$6.57M	Buy	1,066 +394	+59%	+$2.86M	﹤0.01%	2936
2020 Q4	$3.82M	Buy	672 +138	+26%	+$867K	﹤0.01%	3097
2020 Q3	$3.19M	Buy	534 +128	+32%	+$747K	﹤0.01%	3008
2020 Q2	$2.53M	Buy	406 +216	+114%	+$1.46M	﹤0.01%	3085
2020 Q1	$1.83M	Buy	190 +117	+160%	+$1.84M	﹤0.01%	3100
2019 Q4	$1.21M	Buy	73 +6	+9%	+$100K	﹤0.01%	3370
2019 Q3	$1.08M	Buy	67 +9	+16%	+$145K	﹤0.01%	3379
2019 Q2	$1.25M	Buy	58 +21	+57%	+$520K	﹤0.01%	3379
2019 Q1	$1.04M	Sell	37 -14	-27%	-$336K	﹤0.01%	3329
2018 Q4	$756K	Buy	51 +13	+34%	+$291K	﹤0.01%	3380
2018 Q3	$1.34M	Buy	38 +12	+46%	+$370K	﹤0.01%	3357
2018 Q2	$759K	Buy	26 +2	+8%	+$77.7K	﹤0.01%	3431
2018 Q1	$3.31M	Buy	+24	New	+$2.92M	﹤0.01%	2972

Other funds holding YARW

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

T3 Companies New York $93.7M AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KCA

KVP Capital Advisors San Francisco, California $134M AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street's YARW Position: Q1 2026 in Review

State Street held its Yarrow Bioscience, Inc. Common Stock (YARW) position steady in Q1 2026 at 315 shares worth $9.42K. The position accounts for ﹤0.01% of the portfolio, ranked #4253.

State Street first reported a position in YARW in Q1 2018 and has held it in 33 quarters since. The position peaked at $6.57M in Q1 2021. 42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

State Street held 315 shares of Yarrow Bioscience, Inc. Common Stock worth $9.42K as of Q1 2026.
State Street left its Yarrow Bioscience, Inc. Common Stock share count unchanged in Q1 2026.
Yarrow Bioscience, Inc. Common Stock made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4253 holding.
State Street first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2018 and has held it in 33 quarters since.
State Street's Yarrow Bioscience, Inc. Common Stock position peaked at $6.57M in Q1 2021.
42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.